Your browser doesn't support javascript.
loading
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes.
Komrokji, Rami S; Wei, Sheng; Mailloux, Adam W; Zhang, Ling; Padron, Eric; Sallman, David; Lancet, Jeffrey E; Tinsley, Sara; Nardelli, Lisa A; Pinilla-Ibarz, Javier; Epling-Burnette, Pearlie K; List, Alan F.
Afiliación
  • Komrokji RS; MD Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: rami.komrokji@moffitt.org.
  • Wei S; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Mailloux AW; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Zhang L; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Padron E; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Sallman D; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Lancet JE; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Tinsley S; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Nardelli LA; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Pinilla-Ibarz J; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Epling-Burnette PK; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
  • List AF; MD Moffitt Cancer Center and Research Institute, Tampa, FL.
Clin Lymphoma Myeloma Leuk ; 19(3): 157-161, 2019 03.
Article en En | MEDLINE | ID: mdl-30713125
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Indolamina-Pirrol 2,3,-Dioxigenasa Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Indolamina-Pirrol 2,3,-Dioxigenasa Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article